193 related articles for article (PubMed ID: 35601096)
1. How Yeast Antifungal Resistance Gene Analysis Is Essential to Validate Antifungal Susceptibility Testing Systems.
Pellaton N; Sanglard D; Lamoth F; Coste AT
Front Cell Infect Microbiol; 2022; 12():859439. PubMed ID: 35601096
[TBL] [Abstract][Full Text] [Related]
2. Comparative assessment of Sensititre YeastOne and Micronaut-AM EUCAST for antifungal susceptibility testing in candidaemia isolates.
Bélik F; Deckers C; Khourssaji M; Huang TD; Denis O; Montesinos I
J Mycol Med; 2024 Mar; 34(1):101465. PubMed ID: 38401236
[TBL] [Abstract][Full Text] [Related]
3. The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds.
Espinel-Ingroff A; Turnidge J
Rev Iberoam Micol; 2016; 33(2):63-75. PubMed ID: 27296911
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Two Commercial Colorimetric Broth Microdilution Tests for
Philips S; Van Hoecke F; De Laere E; Vervaeke S; De Smedt R; Boelens J; De Geyter D; Piérard D; Lagrou K
J Fungi (Basel); 2021 May; 7(5):. PubMed ID: 34062848
[TBL] [Abstract][Full Text] [Related]
5. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
6. Overestimation of Amphotericin B Resistance in Candida auris with Sensititre YeastOne Antifungal Susceptibility Testing: a Need for Adjustment for Correct Interpretation.
Siopi M; Peroukidou I; Beredaki MI; Spruijtenburg B; de Groot T; Meis JF; Vrioni G; Tsakris A; Pournaras S; Meletiadis J
Microbiol Spectr; 2023 Jun; 11(3):e0443122. PubMed ID: 37036351
[TBL] [Abstract][Full Text] [Related]
7. Etest and Sensititre YeastOne Susceptibility Testing of Echinocandins against Candida Species from a Single Center in Austria.
Aigner M; Erbeznik T; Gschwentner M; Lass-Flörl C
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559257
[No Abstract] [Full Text] [Related]
8. Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
Pfaller MA; Chaturvedi V; Diekema DJ; Ghannoum MA; Holliday NM; Killian SB; Knapp CC; Messer SA; Miskou A; Ramani R
Diagn Microbiol Infect Dis; 2012 Aug; 73(4):365-8. PubMed ID: 22726528
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the Vitek 2 antifungal susceptibility system with the clinical and laboratory standards institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the Sensititre YeastOne and Etest techniques for in vitro detection of antifungal resistance in yeast isolates.
Cuenca-Estrella M; Gomez-Lopez A; Alastruey-Izquierdo A; Bernal-Martinez L; Cuesta I; Buitrago MJ; Rodriguez-Tudela JL
J Clin Microbiol; 2010 May; 48(5):1782-6. PubMed ID: 20220169
[TBL] [Abstract][Full Text] [Related]
10. Antifungal susceptibility testing results of New Zealand yeast isolates, 2001-2015: Impact of recent CLSI breakpoints and epidemiological cut-off values for Candida and other yeast species.
Morris AJ; Rogers K; McKinney WP; Roberts SA; Freeman JT
J Glob Antimicrob Resist; 2018 Sep; 14():72-77. PubMed ID: 29486358
[TBL] [Abstract][Full Text] [Related]
11. Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
Matsumoto FE; Dias AL; Melhem MS; Szeszs MW; Auler ME; Ruiz LS; Gonçalves da Silva E; Gandra RF; Paula CR
Can J Microbiol; 2007 Dec; 53(12):1300-6. PubMed ID: 18059562
[TBL] [Abstract][Full Text] [Related]
12. Multisite reproducibility of MIC results by the Sensititre YeastOne colorimetric antifungal susceptibility panel.
Pfaller MA; Messer SA; Hollis RJ; Espinel-Ingroff A; Ghannoum MA; Plavan H; Killian SB; Knapp CC
Diagn Microbiol Infect Dis; 1998 Aug; 31(4):543-7. PubMed ID: 9764393
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species.
Chryssanthou E; Cuenca-Estrella M
J Clin Microbiol; 2002 Oct; 40(10):3841-4. PubMed ID: 12354895
[TBL] [Abstract][Full Text] [Related]
14. Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.
Arendrup MC; Cuenca-Estrella M; Lass-Flörl C; Hope WW
Drug Resist Updat; 2013 Dec; 16(6):81-95. PubMed ID: 24618110
[TBL] [Abstract][Full Text] [Related]
15. Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values.
Arendrup MC; Prakash A; Meletiadis J; Sharma C; Chowdhary A
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28416539
[No Abstract] [Full Text] [Related]
16. Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of
Espinel-Ingroff A; Turnidge J; Alastruey-Izquierdo A; Dannaoui E; Garcia-Effron G; Guinea J; Kidd S; Pelaez T; Sanguinetti M; Meletiadis J; Botterel F; Bustamante B; Chen YC; Chakrabarti A; Chowdhary A; Chryssanthou E; Córdoba S; Gonzalez GM; Guarro J; Johnson EM; Kus JV; Lass-Flörl C; Linares-Sicilia MJ; Martín-Mazuelos E; Negri CE; Pfaller MA; Tortorano AM
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437624
[TBL] [Abstract][Full Text] [Related]
17. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
Pfaller MA; Diekema DJ; Procop GW; Rinaldi MG
Diagn Microbiol Infect Dis; 2013 Sep; 77(1):37-40. PubMed ID: 23870164
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of the Sensititre YeastOne® panel to detect Candida species resistant to antifungal drugs].
Córdoba S; Abiega C; Agorio I; Amigot S; Ardizzoli K; Giusiano G; Guelfand L; López Moral L; Maldonado I; Pineda G; Garcia-Effron G;
Rev Argent Microbiol; 2022; 54(1):9-14. PubMed ID: 33875292
[TBL] [Abstract][Full Text] [Related]
20. The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro.
Cuenca-Estrella M; Rodriguez-Tudela JL
Expert Rev Anti Infect Ther; 2010 Mar; 8(3):267-76. PubMed ID: 20192681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
